Preprint · OA
via OpenAlex
Understanding the role of metformin in Alzheimer's disease
UCL Discovery (University College London) · 2025
Abstract
Alzheimer’s disease, the most common form of dementia, represents a profound global health burden with urgent need for therapies. Metformin, the first-line drug to treat type II diabetes, is being explored as a potential therapy to treat Alzheimer’s disease following promising results from small-scale clinical trials in patients with mild cognitive impairment that suggest a beneficial role of metformin in ameliorating cognitive decline. However, in vitro experiments report metformin may potentially worsen the disease by increasing the generation of Amyloid-β (Aβ), a widely believed driving force of the pathogenesis of Alzheimer’s disease. To better understand metformin’s role in Alzheimer’s disease, a genetic screen was performed in an Aβproducing Drosophila model for metformin-regulated genes that modify Aβ-associated climbing defect. Multiple candidate suppressors and enhancers of Aβ toxicity were identified, and further validations suggested that the upregulation of rngo (rings lost), which encodes an extraproteasomal ubiquitin receptor, was the best suppressor of toxicity. Metformin could stabilise the rngo protein, possibly through a direct association. The human ortholog of rngo, DDI2 (DNA Damage Inducible 1 Homolog 2), plays a key role in maintaining protein homeostasis, which is in line with the results in flies that both metformin and rngo overexpression could enhance resistance against proteasomal stress. Metformin also suppressed the accumulation of poly-ubiquitinated proteins in human iPSC-derived neurons under proteasome inhibition. Collectively, this project identified a novel target and effector of metformin, rngo/DDI2, that may explain metformin’s benefits in ameliorating Aβ toxicity.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- OpenAlex
- Canonical
- link ↗
- Fetched
- 2026-11-08 MST
Cite this
APA
Dongwei, X. (2025). Understanding the role of metformin in Alzheimer's disease. <em>UCL Discovery (University College London)</em>. https://openalex.org/W7112273720
Vancouver
Dongwei X. Understanding the role of metformin in Alzheimer's disease. UCL Discovery (University College London). 2025.
BibTeX
@unpublished{xu2025Unders,
title = {Understanding the role of metformin in Alzheimer's disease},
author = {Xu, Dongwei},
journal = {UCL Discovery (University College London)},
year = {2025},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Journal of Alzheimer s Disease 2017
Open access · OA
Oxidative Stress, Synaptic Dysfunction, and Alzheimer’s Disease
Frontiers in Neuroscience 2017
Open access · CC-BY
The Hsp70/Hsp90 Chaperone Machinery in Neurodegenerative Diseases
Gregory Jicha, MD, PhD 2021
Open access · US-GOV
Safety and Modulation of ABCC9 Pathways by Nicorandil for the Treatment of Hippocampal Sclerosis of Aging: SMArT-HS
Neural Regeneration Research 2023
Open access · CC-BY
The role of natural flavonoids on neuroinflammation as a therapeutic target for Alzheimer’s disease: a narrative review
Bratislavské lekárske listy/Bratislava medical journal 2006
Citation only
The role of oxidative stress in the pathogenesis of Alzheimer's disease
Molecular Neurobiology 2012
Citation only